Matthias Lohmann is an experienced professional in the field of immunology and inflammation research, currently serving as a Project Leader and Lab Head at Sanofi since 2006. Prior roles at Sanofi-Aventis Deutschland GmbH and Aventis Deutschland GmbH included positions as a Research Scientist and Postdoctoral Fellow, focusing on metabolism and type 2 diabetes genomics, respectively. Earlier experience at Heart Biosystems GmbH involved developing innovative therapies for cardiovascular diseases and supervising laboratory personnel. Matthias Lohmann holds a PhD in Biology with a focus on molecular and cellular biology, immunology, and toxicology from Johannes Gutenberg University Mainz and has further educational background from Aberystwyth University.